BMJ Paediatrics Open (May 2024)

Comparative efficacy of volume expansion, inotropes and vasopressors in preterm neonates with probable transitional circulatory instability in the first week of life: a systematic review and network meta-analysis

  • Kumar Praveen,
  • Deepak Sharma,
  • Kiran More,
  • Pradeep Suryawanshi,
  • Abhishek Somasekhara Aradhya,
  • Supreet Khurana,
  • Viraraghavan V Ramaswamy,
  • Gunjana Kumar,
  • Pullattayil Abdul kareem,
  • Mohit Sahni,
  • Saini Shiv Sajan,
  • Kanithi Ravishankar,
  • Dhir Shashi Kant

DOI
https://doi.org/10.1136/bmjpo-2024-002500
Journal volume & issue
Vol. 8, no. 1

Abstract

Read online

Background There exists limited agreement on the recommendations for the treatment of transitional circulatory instability (TCI) in preterm neonatesObjective To compare the efficacy of various interventions used to treat TCIMethods Medline and Embase were searched from inception to 21st July 2023. Two authors extracted the data independently. A Bayesian random effects network meta-analysis was used. Recommendations were formulated using the Grading of Recommendations, Assessment, Development, and Evaluations (GRADE) framework.Interventions Dopamine, dobutamine, epinephrine, hydrocortisone, vasopressin, milrinone, volume and placebo.Main outcome measures Mortality, major brain injury (MBI) (intraventricular haemorrhage > grade 2 or cystic periventricular leukomalacia), necrotising enterocolitis (NEC) ≥stage 2 and treatment response (as defined by the author).Results 15 Randomized Controlled Trials (RCTs) were included from the 1365 titles and abstracts screened. Clinical benefit or harm could not be ruled out for the critical outcome of mortality. For the outcome of MBI, epinephrine possibly decreased the risk when compared to dobutamine and milrinone (very low certainty). Epinephrine was possibly associated with a lesser risk of NEC when compared with dopamine, dobutamine, hydrocortisone and milrinone (very low certainty). Dopamine was possibly associated with a lesser risk of NEC when compared with dobutamine (very low certainty). Vasopressin possibly decreased the risk of NEC compared with dopamine, dobutamine, hydrocortisone and milrinone (very low certainty). Clinical benefit or harm could not be ruled out for the outcome response to treatment.Conclusions Epinephrine may be used as the first-line drug in preterm neonates with TCI, the evidence certainty being very low. We suggest future trials evaluating the management of TCI with an emphasis on objective criteria to define it.